| 000 | 01832 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516023019.0 | ||
| 264 | 0 | _c20110726 | |
| 008 | 201107s 0 0 eng d | ||
| 022 | _a1872-6623 | ||
| 024 | 7 |
_a10.1016/j.pain.2010.12.029 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKodama, Daisuke | |
| 245 | 0 | 0 |
_aIncreased hippocampal glycine uptake and cognitive dysfunction after peripheral nerve injury. _h[electronic resource] |
| 260 |
_bPain _cApr 2011 |
||
| 300 |
_a809-817 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCognition Disorders _xetiology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aExcitatory Postsynaptic Potentials _xdrug effects |
| 650 | 0 | 4 |
_aExploratory Behavior _xphysiology |
| 650 | 0 | 4 |
_aFluoroacetates _xpharmacology |
| 650 | 0 | 4 |
_aGlycine _xmetabolism |
| 650 | 0 | 4 | _aHerb-Drug Interactions |
| 650 | 0 | 4 |
_aHippocampus _xmetabolism |
| 650 | 0 | 4 |
_aHyperalgesia _xdrug therapy |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred Strains |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aN-Methylaspartate _xpharmacology |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 | _aPain Measurement |
| 650 | 0 | 4 |
_aPain Threshold _xphysiology |
| 650 | 0 | 4 | _aPatch-Clamp Techniques |
| 650 | 0 | 4 | _aRecognition, Psychology |
| 650 | 0 | 4 |
_aSarcosine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aSciatic Neuropathy _xcomplications |
| 700 | 1 | _aOno, Hideki | |
| 700 | 1 | _aTanabe, Mitsuo | |
| 773 | 0 |
_tPain _gvol. 152 _gno. 4 _gp. 809-817 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pain.2010.12.029 _zAvailable from publisher's website |
| 999 |
_c20573847 _d20573847 |
||